“The DxH 690T leverages flagship products in the Beckman Coulter Diagnostics’ portfolio, specifically the enhanced Coulter Principle, VCS technology and DataFusion, to provide precise cellular assessments of RBCs, WBCs and platelets. With 93% first-pass yield and 75% fewer quality control steps compared to other commercially-available systems, the DxH 690T provides laboratories a more streamlined workflow with increased uptime and lower overhead costs. The company developed the tabletop hematology analyzer for mid-volume laboratories, community hospitals, and physician offices, without compromising clinical effectiveness. SeptemBased on its recent analysis of the global hematology testing market, Frost & Sullivan recognizes Beckman Coulter Diagnostics with the 2020 Global New Product Innovation Award for the DxH 690T. Information & Communications Technologies.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |